Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2025)

Autolus Therapeutics (AUTL) has disclosed Gross Margin for 2 consecutive years, with 35.15% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Margin changed N/A year-over-year to 35.15%, compared with a TTM value of 61.24% through Sep 2025, changed N/A, and an annual FY2024 reading of 12.52%, down 11252.0% over the prior year.
  • Gross Margin was 35.15% for Q3 2025 at Autolus Therapeutics, down from 16.83% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q1 2024 and bottomed at 56835.0% in Q4 2024.